Open-angle glaucoma is an eye disease that causes a gradual loss of vision. It is the most common type of glaucoma, a set of eye diseases that affect the eye's optic nerve. The optic nerve is ...

Dihydropyridine CCBs may raise the risk of glaucoma, suggests a study published in the Ophthalmology Glaucoma.A study was ...

Simple reaction time tasks given to patients living with glaucoma had different response times based on whether the task was visual or auditory, according to a new study published in the European ...

H-1337 is under clinical development by D. Western Therapeutics Institute and currently in Phase II for Open-Angle Glaucoma.

Sigma-2 receptor modulation using exogenous ligands reduces cellular damage associated with central nervous system degeneration in age-related pathologies such as Alzheimer’s disease, Parkinson’s ...

Iantrek’s CREST Registry reports 1-year outcomes for a bio-interventional glaucoma treatment, demonstrating significant IOP ...

The glaucoma treatment landscape is shifting towards advanced surgical options, fueled by an aging population and greater ...